Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech’s COVID-19 vaccine called Covaxin during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, Jan. 16, 2021. (REUTERS)
India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.
The company said a booster dose was given to trial participants six months after they received their second dose.
MOST READ
LATEST STORIES